SHANNON MCBAIN: Open Payments
NPI 1427177054 · GRASS VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,445 in 52 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $943 · 2025 $1,445
Food & beverage: $1,445
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $301 |
| Daiichi Sankyo Inc. | 6 | $218 |
| PFIZER INC. | 14 | $198 |
| Novartis Pharmaceuticals Corporation | 8 | $180 |
| Merck Sharp & Dohme LLC | 7 | $178 |
| E.R. Squibb & Sons, L.L.C. | 1 | $106 |
| Amgen Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Baxter Healthcare | 1 | $34 |
Products named: AVEIR, INJECTAFER, LEQVIO, VERQUVO, VYNDAQEL, CAMZYOS, ELIQUIS, REPATHA.
Industry payments across CA — which companies pay providers there.
